Numinus CEO Payton Nyquvest Says Psychedelic Therapy Shouldn’t Be The ‘Last’ Option For Treatment Nov 21, 2021
Meet Clinical Researcher Najla Guthrie, The Founder, President and CEO Of KGK… Amanda Siebert Dec 3, 2021
Does the Oversimplification of Scientific Studies Lead to Misinterpretation? Nicolle Hodges Dec 3, 2021
Revive Therapeutics Expands Bucillamine Research to Treat Omicron Variant and Adds… Louise Sommerfeld Dec 3, 2021
Liquid Meta Developing Advanced DeFi Applications For The Institutional Masses Benjamin A. Smith Dec 2, 2021
